Names without a link are companies not yet registered in OpenBizGraph
§05
Network
NETWORK
Loading the relationship graph...
Drag to move · click to open
§06
History
58 EVENTS
Commenced drugstore operations
Acquired the Okayama regional sales rights from Drag Lion Co., Ltd. and commenced operations as the Chūshikoku Division
Absorbed and split the Chūshikoku Division and changed the company name to Chūshikoku Seims Co., Ltd.
Alpha Co., Ltd. acquired part of the business of Lion Create Co., Ltd. and changed the company name to Tōhoku Seims Co., Ltd.
Chūshikoku Seims Co., Ltd. absorbed and merged with Drag Store Cosmos 21 Co., Ltd. and changed the company name to Nishi-Nippon Seims Co., Ltd.
Established Tokai Seims Co., Ltd.
Just Drug Co., Ltd. absorbed and merged with Shibata Pharmaceutical Co., Ltd. and changed the company name to Kanto Seims Co., Ltd.
Opened the first Drag Seims (Imis) store in Shanghai.
Absorbed and merged with Drag Store Bygo Co., Ltd.
Absorbed and merged with Kanto Seims Co., Ltd.
Absorbed and merged with Tōhoku Seims Co., Ltd. and S Road Co., Ltd.
Acquired all shares of Kyūmei-dō Co., Ltd.
Nippon Co., Ltd. inherited and acquired the pharmacy dispensing business owned by a subsidiary of the Health Science Group Headquarters.
Hosted the first edition of the International Tennis Federation-sanctioned tournament 'Fuji Pharmaceutical Seims Women's Cup'.
Absorbed and merged with Kyushu Seims Co., Ltd. and Kyūmei-dō Co., Ltd.
Retreated from Shanghai.
Application for manufacturing and marketing approval of the gout and hyperuricemia drug FYU-981 (generic name: docetaxel) in Japan.
Hosted the ITF Circuit Fuji Pharmaceutical Seims Women's Cup 3 tournaments (Osaka Sports University tournament in February, Kofu tournament in March, Osaka tournament in April).
Liquidated China National Chemical Life Science Technology Co., Ltd. (Samoa Bio Co., Ltd.).
Mori Co., Ltd. absorbed and merged with Tohoku Seims Co., Ltd.
Acquired all shares of Amihama Pharmacy Co., Ltd.
Signed a contract with professional women's tennis player Sato Kumanari.
Signed a sponsorship agreement with professional women's golf player Morita Haruka.
Accepted inspection toward obtaining FDA (U.S. Food and Drug Administration) certification at the Toyama Second Factory.
Obtained manufacturing and marketing approval in Japan for the hyperuricemia drug Yuris® tablets (generic name: docetaxel).
Signed a license agreement for the development and sale of the hyperuricemia drug Yuris® tablets (generic name: docetaxel) in China.
Absorbed and merged with Smile Drug Co., Ltd.
Acquired all shares of Taiyodō Co., Ltd.
Established the Tokyo headquarters in Chiyoda-ku, Tokyo, and relocated headquarters functions.
Commenced sales of the hyperuricemia drug Yuris® tablets (generic name: docetaxel).
Transferred part of the rights and obligations related to the insurance pharmacy business of Nissho Co., Ltd. to Mori Co., Ltd. through a corporate split.
Assumed all remaining rights and obligations except those subject to the aforementioned corporate split and absorbed Nissho Co., Ltd.
Announced the signing of an exclusive license agreement with Fortress Biotech, Inc. for the development and sale of the hyperuricemia drug Yuris® tablets (generic name: docetaxel) in North America and Europe.
Seims signed a top partner agreement with Omiya Ardija Ventus, which entered Japan's first women's professional soccer league WE League in September 2021.
Formulated the Fuji Pharmaceutical Group slogan.
Signed a license agreement with Eisai for the development and sale of the hyperuricemia drug Yuris® tablets (generic name: docetaxel) in five ASEAN countries.
Subsidiary Yutaka Pharmacy Co., Ltd. absorbed Taiyodo Co., Ltd. in a merger.
Entered into an exclusive license agreement with Standard Chemical & Pharmaceutical Co., Ltd. for the development and sale of Ulysses® tablets in Taiwan.
Certified as a Health & Productivity Management Outstanding Organization (White 500).
Signed a sponsorship agreement with women's professional golfer Ayumi Yamada.
Signed a comprehensive partnership agreement with Uonuma City, Niigata Prefecture, on health promotion, launching collaborative initiatives with local governments.
Received Silver certification under the PRIDE Index, an evaluation index for initiatives supporting sexual minorities, including LGBTQ+ people.
Expanded the territory covered by its exclusive license agreement with Fortress Biotech, Inc. for the development and sale of Ulysses® tablets to include the Middle East and North Africa, including Turkey.
Certified as a Health & Productivity Management Outstanding Organization (White 500) for the second consecutive year.
Launched health and productivity management support services for companies with contracts for its prescription medicine delivery service.
Began offering disaster-prevention supplies to companies with contracts for its prescription medicine delivery service.
Introduced Seims Touch at all Fuji Yakuhin Group drugstores except Drug Yutaka.
Relocated the First Research Laboratory to Shonan Health Innovation Park (2-26-1 Muraoka-Higashi, Fujisawa City, Kanagawa Prefecture).
Received the highest rating, Gold, in the 2023 PRIDE Index, which evaluates initiatives supporting sexual minorities, including LGBTQ+ people.
Kyowa Shoji Co., Ltd. left the Fuji Yakuhin Group following its response to the company's acquisition of its own shares.
Certified as a Health & Productivity Management Outstanding Organization (White 500) for the third consecutive year.
Signed an affiliation agreement with tennis player Sakura Saito.
Relocated the Omiya headquarters to AddGrace Omiya (1-398-1 Sakuragi-cho, Omiya-ku, Saitama City, Saitama Prefecture).
Rakuten Point Cards became usable at Fuji Yakuhin Group drugstores, including Seims.
Certified under the Ministry of Health, Labour and Welfare's Kurumin Plus program.
Dochynurad, a treatment for gout and hyperuricemia, received approval in Thailand.
Received the 'Gold' award, the highest rating, for two consecutive years in the PRIDE 2024 indicator evaluating efforts toward LGBTQ+ and other sexual minorities.
The gout and hyperuricemia drug 'Docinurad' received approval in China for the indication of gout associated with hyperuricemia.
§07
News
248 ARTICLES
Online Shop Exclusive 5% OFF Coupon Distribution & Daily Points 10x Promotion
At the official online shop of Drag Seims, a 5% OFF coupon is distributed exclusively to online members during the Black Friday campaign. The coupon acquisition period is from 12:00 on November 12 to 23:59 on November 13. The coupon usage period is from 0:00 to 23:59 on November 13, and during this time, daily points are also multiplied by 10.
5% OFF Coupon Distribution for Online Shopping Members Only & 10x Daily Points
At the official online shop of Drag Seims, a 5% OFF coupon is distributed exclusively to online shopping members during the Black Friday campaign. The coupon acquisition period is from 12:00 on November 5 to 23:59 on November 6, and the usage period is from 0:00 to 23:59 on November 6. Additionally, during the Black Friday period, daily points are multiplied by 10.
In November, the Drag Seams official online shop will run a Black Friday campaign. During the period, points will be multiplied by 10 every day, and a special member-only coupon will be distributed every Friday. Almost all products are eligible, but some exclusions apply, so please check the official site for details.
New Pharmacy Opening Announcement (November 2026)
Fuji Pharmaceutical Group will open several new pharmacies in November 2026. The main stores are Chaya-cho Pharmacy, Inazawa Koike Pharmacy, Hikone Matsubara Pharmacy, Omi Yawata Juu-ō Pharmacy, Kohama Chikusa Pharmacy, Uehirose Pharmacy, and Kabihei Pharmacy. The opening dates for each store are November 2, and phone numbers and addresses are listed.
Notice of Drag Seims Store Renewal Opening
From November 1 to 30, 2026, several Drag Seims stores will be renewed and reopened. We will provide comfortable shopping in a new space, and there will be temporary closures for construction before opening. Opening dates may change.
Fixing Re-login Issues Caused by App Update
The logout, re-login, and Rakuten Points display issues that occurred after the app renewal are resolved by updating to the latest version (Ver. 4.0.3). iPhone users should update from the App Store and restart the app. If the login state is not restored, please use the standard login or SMS authentication.
Announcement of new pharmacy opening in October 2026
A new pharmacy will open in October 2026. Five stores of Drug Seims and two stores of Drug Yutaka are listed, and the opening dates are October 1 for six stores, and Yutaka Pharmacy Keitanba on October 5.
October Store Renovations and Reopenings
From October 1 to 31, 2026, stores in the Fuji Pharmaceutical Group will reopen after renovations. At Drug Seims, the stores involved are Gyoda Oshiage, Tokigawa, Osaka Sayama, and Minami-Koiwa 7-chome. The stores will be temporarily closed for construction before reopening, and the reopening dates are subject to change.
Apology for Incorrect Awarding of Campaign Lottery Points
In the “Summer Special Jumbo Campaign Part 2,” an error in the point-awarding process on September 24 resulted in points being awarded that differed from the actual lottery results. The company notified affected customers of the details and apologized in the app, and says it has corrected the points to reflect the proper results.
Issues with Logging Back Into the App and Congestion at Customer Support
Since the SEIMS app was renewed on September 8, users have experienced issues such as being unable to log back in and Rakuten Points not displaying correctly. Responses to phone calls and inquiries submitted via the contact form are also taking time. We are currently investigating the causes and working on fixes. Points earned before the renewal have been retained along with member information and can continue to be used after logging back in successfully.